Mahmoud H. Mosli
Consultant Gastroenterologist, Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (16)
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Ulcerative colitis (UC) is a chronic autoimmune inflammatory disease that affects the colon, leading to symptoms of bloody diarrhea, abdominal cramps, and urgency. The treatment of UC has evolved over the past few decades from locally active anti-inflammatory compounds to more selective therapies that target specific arrays of the immune system. The challenge of selecting the first advanced therapy became apparent in this rapidly expanding landscape of medications. No current investigational tools, such as genetic, immunologic, or biological markers, can guide the identification of the safest and most effective therapeutic option for each patient. Hence, physicians must carefully assess patient/disease characteristics and match them with the most suitable drug through a clinically driven assessment. In this paper, we outline patient and drug characteristics that play a role in selecting first-line advanced therapies for UC and propose an algorithm for selection.
Year:
2024
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (5)
Nahla Azzam
Associate Professor
king saud university
Maan Alkhattabi
Assistant Professor
king abdulaziz university
Yasser Bawazir
Assistant professor of Medicine and Rheumatology
king abdulaziz university
Nadeem Shafique Butt
Professor
king abdulaziz university
Doaa Anbarserry
Assistant Professor
king abdulaziz university
Make your next move.
Prepare your application
Review drafts before you send them.